Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study-Reference-Cited by-同舟云学术

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study

Published:2013-12 Issue:12 Volume:24 Page:3035-3039
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Watson S.,Validire P.,Cervera P.,Zorkani N.,Scriva A.,Lemay F.,Tournigand C.,Perniceni T.,Garcia M-L.,Bennamoun M.,Paye F.,Louvet C.

Funder

Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/12/3035/16702165/mdt393.pdf

Reference26 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol Biomarkers Prev.,2010

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med.,2006

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

4. Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial;Ferri;Ann Oncol,2012

5. The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract;Matuschek;Eur J Med Res.,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study;Digestive and Liver Disease;2024-01

2. Assessment of the reliability of MSI status and dMMR proteins deficiency screening on endoscopic biopsy material in esophagus and gastric adenocarcinoma;Digestive and Liver Disease;2023-08

3. Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers;Proceedings of the National Academy of Sciences;2023-03-27

4. Dynamic detection of HER2 of circulating tumor cells in patients with gastric carcinoma and its clinical application;Molecular Medicine Reports;2022-03-28

5. High Concordance of HER2 Overexpression by Immunohistochemistry on Mucosal Biopsies and Resection in Gastric Adenocarcinoma;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2021